Impact of the IMbrave150 Trial: Evolving Standards of Care for Advanced HCC (Americas & Europe)
Impact of the IMbrave150 Trial: Evolving Standards of Care for Advanced HCC (Americas & Europe)
Prof. Dr. Peter R. Galle
View this summary of the April 2020 HCC Experts Round Table meeting (Americas & Europe) and download the accompanying educational slide set for more information.
Prof. Dr. Peter R. Galle
Hepatologist
University of Mainz
Germany
Video | 
5 min
|
Apr 2020
download resources
I agree that this educational programme:
The HCC Experts Round Table (Americas & Europe) brought together international experts in hepatocellular carcinoma. This interdisciplinary group (oncology, hepatology, radiology, patient advocacy, and health economics) explored evolving standards of care for advanced first-line HCC, particularly in light of IMbrave150 phase III clinical trial data. Follow the link above to view the recent publication announcement from the HCC Experts Round Table.
Other programmes of interest
5 min
Other programmes developed by Prof. Dr. Peter R. Galle
Prof. Dr. Peter R. Galle
Hepatologist
University of Mainz
Germany
